Published in Head Neck on April 01, 2011
The role of JAK/STAT signalling in the pathogenesis, prognosis and treatment of solid tumours. Br J Cancer (2015) 1.03
Frequent mutation of receptor protein tyrosine phosphatases provides a mechanism for STAT3 hyperactivation in head and neck cancer. Proc Natl Acad Sci U S A (2014) 1.01
Periodontal pathogens Porphyromonas gingivalis and Fusobacterium nucleatum promote tumor progression in an oral-specific chemical carcinogenesis model. Oncotarget (2015) 0.94
STAT3 in Cancer-Friend or Foe? Cancers (Basel) (2014) 0.93
Characterization of STAT3 expression, signaling and inhibition in feline oral squamous cell carcinoma. BMC Vet Res (2015) 0.84
Overexpression of nucleostemin contributes to an advanced malignant phenotype and a poor prognosis in oral squamous cell carcinoma. Br J Cancer (2014) 0.83
Prognostic role of STAT3 in solid tumors: a systematic review and meta-analysis. Oncotarget (2016) 0.82
Prognostic Significance of Serine-Phosphorylated STAT3 Expression in pT1-T2 Oral Tongue Carcinoma. Clin Exp Otorhinolaryngol (2015) 0.80
Impact of warm ischemia on phosphorylated biomarkers in head and neck squamous cell carcinoma. Am J Transl Res (2014) 0.75
MPT0B098, a Microtubule Inhibitor, Suppresses JAK2/STAT3 Signaling Pathway through Modulation of SOCS3 Stability in Oral Squamous Cell Carcinoma. PLoS One (2016) 0.75
Clinical, endoscopic, and histological differentiations between Crohn's disease and intestinal tuberculosis. Am J Gastroenterol (2010) 2.70
Short course palliative radiotherapy of 20 Gy in 5 fractions for advanced and incurable head and neck cancer: AIIMS study. Radiother Oncol (2004) 2.25
Tropical pyomyositis (myositis tropicans): current perspective. Postgrad Med J (2004) 1.93
Issues associated with the emergence of coeliac disease in the Asia–Pacific region: a working party report of the World Gastroenterology Organization and the Asian Pacific Association of Gastroenterology. J Gastroenterol Hepatol (2014) 1.83
Sequential occurrence of preneoplastic lesions and accumulation of loss of heterozygosity in patients with gallbladder stones suggest causal association with gallbladder cancer. Ann Surg (2014) 1.82
Discovery and verification of head-and-neck cancer biomarkers by differential protein expression analysis using iTRAQ labeling, multidimensional liquid chromatography, and tandem mass spectrometry. Mol Cell Proteomics (2008) 1.76
Quantitative proteomic analysis in metastatic renal cell carcinoma reveals a unique set of proteins with potential prognostic significance. Mol Cell Proteomics (2012) 1.72
Adult subacute mountain sickness--a syndrome of congestive heart failure in man at very high altitude. Lancet (1990) 1.52
Clinical features and prognostic factors of early breast cancer at a major cancer center in North India. Indian J Cancer (2005) 1.48
Evaluation of mediastinal lymph nodes using F-FDG PET-CT scan and its histopathologic correlation. Ann Thorac Med (2011) 1.47
Idiopathic duro-optic calcification--a new entity? Clin Radiol (1996) 1.41
The changed clinical spectrum of malaria due to drug resistance. J Assoc Physicians India (1998) 1.39
Inhalable microparticles containing large payload of anti-tuberculosis drugs. Eur J Pharm Sci (2007) 1.39
Identification of differentially expressed genes in oral squamous cell carcinoma. Mol Carcinog (2005) 1.36
Regulation of mdr RNA levels in response to cytotoxic drugs in rodent cells. Cell Growth Differ (1990) 1.32
Expression analysis of E-cadherin, Slug and GSK3beta in invasive ductal carcinoma of breast. BMC Cancer (2009) 1.29
The prevalence and epidemiology of toxoplasmosis in Ontario. J Hyg (Lond) (1977) 1.29
Production of multiple xylanolytic and cellulolytic enzymes by thermophilic fungus Myceliophthora sp. IMI 387099. Bioresour Technol (2006) 1.27
KIF1A and EDNRB are differentially methylated in primary HNSCC and salivary rinses. Int J Cancer (2010) 1.26
Incidence, etiopathogenesis and pathological aspects of genitourinary tuberculosis in India: A journey revisited. Indian J Urol (2008) 1.22
An improved method for RNA isolation and cDNA library construction from immature seeds of Jatropha curcas L. BMC Res Notes (2010) 1.21
Links between DNA double strand break repair and breast cancer: accumulating evidence from both familial and nonfamilial cases. Cancer Lett (2006) 1.21
Promoter hypermethylation of TMS1, BRCA1, ERalpha and PRB in serum and tumor DNA of invasive ductal breast carcinoma patients. Life Sci (2007) 1.20
Curcumin down regulates smokeless tobacco-induced NF-kappaB activation and COX-2 expression in human oral premalignant and cancer cells. Toxicology (2006) 1.18
Promoter hypermethylation of p16INK4A, p14ARF, CyclinD2 and Slit2 in serum and tumor DNA from breast cancer patients. Life Sci (2007) 1.17
68Ga-DOTANOC PET/CT for baseline evaluation of patients with head and neck paraganglioma. J Nucl Med (2013) 1.17
Overview of current and future biologically based targeted therapies in head and neck squamous cell carcinoma. Head Neck Oncol (2009) 1.16
iTRAQ-multidimensional liquid chromatography and tandem mass spectrometry-based identification of potential biomarkers of oral epithelial dysplasia and novel networks between inflammation and premalignancy. J Proteome Res (2009) 1.16
Guggulsterone, a farnesoid X receptor antagonist, inhibits constitutive and inducible STAT3 activation through induction of a protein tyrosine phosphatase SHP-1. Cancer Res (2008) 1.14
Over-expression of 14-3-3zeta is an early event in oral cancer. BMC Cancer (2007) 1.09
MEMD/ALCAM: a potential marker for tumor invasion and nodal metastasis in esophageal squamous cell carcinoma. Oncology (2005) 1.07
Frequent loss of Dab2 protein and infrequent promoter hypermethylation in breast cancer. Breast Cancer Res Treat (2006) 1.06
Wnt signaling pathway in invasive ductal carcinoma of the breast: relationship between beta-catenin, dishevelled and cyclin D1 expression. Oncology (2008) 1.06
Fetal translocation and metabolism of PAH obtained from coal fly ash given intratracheally to pregnant rats. J Toxicol Environ Health (1986) 1.05
Nuclear S100A7 is associated with poor prognosis in head and neck cancer. PLoS One (2010) 1.04
Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients. Life Sci (2010) 1.04
Heterogeneous ribonucleoprotein K is a marker of oral leukoplakia and correlates with poor prognosis of squamous cell carcinoma. Int J Cancer (2009) 1.03
A rare case of giant leiomyosarcoma in a filarial scrotum: a case report. World J Surg Oncol (2011) 1.03
Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India. Breast Cancer Res Treat (2004) 1.03
Epigenetic alterations of CDH1 and APC genes: relationship with activation of Wnt/beta-catenin pathway in invasive ductal carcinoma of breast. Life Sci (2008) 1.03
Clinical significance of altered expression of β-catenin and E-cadherin in oral dysplasia and cancer: potential link with ALCAM expression. PLoS One (2013) 1.02
Sentinel lymph node biopsy assessment using intraoperative imprint cytology in breast cancer patients: results of a validation study. Asian J Surg (2004) 1.02
Complete response from thalidomide in angiosarcoma after treatment of breast cancer. J Clin Oncol (2007) 1.02
Angiogenesis in cutaneous melanoma: pathogenesis and clinical implications. Microsc Res Tech (2003) 1.02
Stromelysin 3, Ets-1, and vascular endothelial growth factor expression in oral precancerous and cancerous lesions: correlation with microvessel density, progression, and prognosis. Clin Cancer Res (2005) 1.01
Loss of disabled-2 expression is an early event in esophageal squamous tumorigenesis. World J Gastroenterol (2006) 1.01
Expression of DNA methyltransferases in breast cancer patients and to analyze the effect of natural compounds on DNA methyltransferases and associated proteins. J Breast Cancer (2013) 1.01
Prognostic significance of head-and-neck cancer biomarkers previously discovered and identified using iTRAQ-labeling and multidimensional liquid chromatography-tandem mass spectrometry. J Proteome Res (2008) 1.00
Nuclear and cytoplasmic accumulation of Ep-ICD is frequently detected in human epithelial cancers. PLoS One (2010) 1.00
Stromelysin-2 overexpression in human esophageal squamous cell carcinoma: potential clinical implications. Cancer Detect Prev (2002) 0.99
S100A7 overexpression is a predictive marker for high risk of malignant transformation in oral dysplasia. Int J Cancer (2013) 0.99
Potent growth suppressive activity of curcumin in human breast cancer cells: Modulation of Wnt/beta-catenin signaling. Chem Biol Interact (2009) 0.99
Current spectrum of malabsorption syndrome in adults in India. Indian J Gastroenterol (2011) 0.98
Primary malignant melanoma at unusual sites: an institutional experience with review of literature. Melanoma Res (2010) 0.98
Characterization of thymic masses using (18)F-FDG PET-CT. Ann Nucl Med (2009) 0.98
Identification of proteins secreted by head and neck cancer cell lines using LC-MS/MS: Strategy for discovery of candidate serological biomarkers. Proteomics (2011) 0.98
Detection of RASSF1A and RARbeta hypermethylation in serum DNA from breast cancer patients. Epigenetics (2006) 0.97
Novel germline mutations in the BRCA1 and BRCA2 genes in Indian breast and breast-ovarian cancer families. Hum Mutat (2004) 0.97
14-3-3 zeta as novel molecular target for cancer therapy. Expert Opin Ther Targets (2012) 0.96
Prognostic relevance of promoter hypermethylation of multiple genes in breast cancer patients. Cell Oncol (2009) 0.96
Randomized trial comparing neo-adjuvant versus adjuvant chemotherapy in operable locally advanced breast cancer (T4b N0-2 M0). J Surg Oncol (2003) 0.96
Stromelysin-3 expression is an early event in human oral tumorigenesis. Int J Cancer (2003) 0.95
Surgical management of skin cancers: experience from a regional cancer centre in North India. Indian J Cancer (2005) 0.95
Small interfering RNA targeting 14-3-3ζ increases efficacy of chemotherapeutic agents in head and neck cancer cells. Mol Cancer Ther (2010) 0.94
Alterations of rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma. Oncology (2005) 0.94
CpG hypomethylation of MDR1 gene in tumor and serum of invasive ductal breast carcinoma patients. Clin Biochem (2009) 0.94
Expression of NF-kappaB parallels COX-2 expression in oral precancer and cancer: association with smokeless tobacco. Int J Cancer (2007) 0.93
Ets-1 and VEGF expression correlates with tumor angiogenesis, lymph node metastasis, and patient survival in esophageal squamous cell carcinoma. J Cancer Res Clin Oncol (2003) 0.93
Downstream sequences mediate induction of the mouse cathepsin L promoter by phorbol esters. Cell Growth Differ (1991) 0.93
Identification of novel molecular targets for endometrial cancer using a drill-down LC-MS/MS approach with iTRAQ. PLoS One (2011) 0.93
Inflammatory myofibroblastic tumor involving lung and brain in a 10-year-old boy: a case report. J Child Neurol (2009) 0.93
Cytoplasmic accumulation of activated leukocyte cell adhesion molecule is a predictor of disease progression and reduced survival in oral cancer patients. Int J Cancer (2009) 0.92
A rare case of gallbladder carcinoma metastases to the breast treated with curative intent. Trop Gastroenterol (2012) 0.92
Differential expression of G-protein coupled receptor 56 in human esophageal squamous cell carcinoma. Cancer Lett (2006) 0.92
Promoter hypermethylation in Indian primary oral squamous cell carcinoma. Int J Cancer (2010) 0.92
Preoperative diagnosis of allergic fungal sinusitis. Laryngoscope (2003) 0.91
Clinical significance of Maspin promoter methylation and loss of its protein expression in invasive ductal breast carcinoma: correlation with VEGF-A and MTA1 expression. Tumour Biol (2010) 0.91
Comparative tight junction protein expressions in colonic Crohn's disease, ulcerative colitis, and tuberculosis: a new perspective. Virchows Arch (2012) 0.90